Logo.png
Foresight Collaborates with One of the World’s Largest Electric Vehicle Brands
29 déc. 2023 07h15 HE | Foresight Autonomous Holdings Ltd.
Parties sign collaboration agreement to evaluate Foresight's 3D perceptioncapabilities for enhancing the manufacturer’s automotive vision solutions Ness Ziona, Israel, Dec. 29, 2023 (GLOBE...
pharmather logo.png
PharmaTher and Vitruvias Enter Into Collaboration Agreement for Commercialization of KETARX™ (racemic ketamine) in the U.S.
20 juin 2023 07h00 HE | PharmaTher Holdings Ltd.
TORONTO, June 20, 2023 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a commercial-focused specialty pharmaceutical company, is pleased to...
Collaboration and Licensing Agreement
18 août 2022 02h00 HE | DXS International PLC
DXS INTERNATIONAL PLC COLLABORATION AND LICENSING AGREEMENT The Board of DXS International plc (“the Company”), the AQSE Growth Market quoted healthcare information and digital clinical decision...
July 30, 2021 - ROSEN LOGO.jpg
STTK SHAREHOLDER ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Shattuck Labs, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – STTK
07 mars 2022 14h01 HE | The Rosen Law Firm PA
NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or...
July 30, 2021 - ROSEN LOGO.jpg
STTK INVESTOR NEWS: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Shattuck Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – STTK
01 févr. 2022 09h45 HE | The Rosen Law Firm PA
NEW YORK, Feb. 01, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...
גרין PNG
Citrine Global Corp.’s (OTCQB: CTGL) Subsidiary, Cannovation Center Israel Ltd., is Pleased to Announce the Launch of its "Green Side by Side" Products Line and the Signing of an Agreement with Intelicanna to Sell the Products in Israel
21 janv. 2022 09h35 HE | Citrine Global, Corp.
Tel Aviv, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp.’s (OTCQB: CTGL) subsidiary, Cannovation Center Israel Ltd. (Cannovation), announced that it has launched its "Green Side by Side"...
Arbutus Biopharma Logo
Arbutus Biopharma and Vaccitech Announce Clinical Trial Collaboration Agreement to Evaluate RNAi Therapeutic, AB-729, in Combination with Immunotherapeutic, VTP-300, in Subjects with Chronic Hepatitis B Virus Infection
06 juil. 2021 07h00 HE | Arbutus Biopharma Corporation
WARMINSTER, Pa. and OXFORD, United Kingdom, July 06, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) and Vaccitech plc (Nasdaq: VACC) today announced that the companies have...
Arbutus Biopharma Logo
Arbutus Biopharma and Antios Therapeutics Announce Clinical Collaboration Agreement to Evaluate AB-729 in Combination with ATI-2173 in Subjects with Chronic Hepatitis B Virus Infection
29 juin 2021 07h00 HE | Arbutus Biopharma Corporation
MENDHAM, N.J. and WARMINSTER, Pa., June 29, 2021 (GLOBE NEWSWIRE) -- Antios Therapeutics, Inc. and Arbutus Biopharma Corporation (Nasdaq: ABUS) today announced that the companies have entered into a...
logo.jpg
GTX Corp Signs Collaboration Agreement with Pawtocol
21 janv. 2021 09h54 HE | GTX Corp
LOS ANGELES, CALIFORNIA, Jan. 21, 2021 (GLOBE NEWSWIRE) -- GTX Corp (OTC: GTXO) (“GTX” or the “Company”), a pioneer in the field of health and safety wearable GPS human and asset tracking systems,...
Logo-uniQure-MS-Word_Orange.jpg
uniQure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters
02 mars 2020 16h05 HE | uniQure Inc.
~ Gen-X Will Work with uniQure During an Exclusivity Period to Identify Novel Promoters for uniQure’s Product Portfolio ~ ~ uniQure Receives Option to Acquire Gen-X Business for Use in Gene Therapy ~...